Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Press Release

    Press Release - Page 12

    DBT launches Sohum - an innovative newborn hearing screening device

    DBT launches Sohum - an innovative newborn hearing screening device

    Ruby Khatun Khatun22 July 2017 9:00 AM IST
    The Honorable Minister of State, Ministry of Science and Technology & Earth Sciences, Shri Y.S. Chowdary, launched Sohum – the newborn hearing...
    QNET Launches Ayurvedic Diabetes Management Supplement in India

    QNET Launches Ayurvedic Diabetes Management Supplement in India

    Ruby Khatun Khatun19 July 2017 9:34 AM IST
    New Delhi: Direct selling company QNET has launched Nutriplus Nature Diabahealth, a health supplement with proprietary Ayurvedic formulation to help...
    Janssen Wins FDA Approval of Tremfya (Guselkumab) for the treatment of Plaque Psoriasis

    Janssen Wins FDA Approval of Tremfya (Guselkumab) for the treatment of Plaque Psoriasis

    Ruby Khatun Khatun18 July 2017 9:53 AM IST
    Horsham, PA: Janssen Biotech, Inc. (Janssen) announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA™ (guselkumab) for the...
    FDA Advisory Committee Recommends Approval of Mylan and Biocon

    FDA Advisory Committee Recommends Approval of Mylan and Biocon's Proposed Biosimilar Trastuzumab

    Ruby Khatun Khatun16 July 2017 9:10 AM IST
    HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India: Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration (FDA)...
    Lupin, American Academy of Ophthalmology Collaborate to  3000 opthalmologists

    Lupin, American Academy of Ophthalmology Collaborate to 3000 opthalmologists

    Ruby Khatun Khatun15 July 2017 9:20 AM IST
    San Francisco and Mumbai: The American Academy of Ophthalmology and Pharma major Lupin Limited (Lupin) announced an agreement that would seek to...
    Huawei Telecommunications contributes infrastructure to Government Hospital of Thoracic Medicine,Chennai

    Huawei Telecommunications contributes infrastructure to Government Hospital of Thoracic Medicine,Chennai

    Ruby Khatun Khatun15 July 2017 9:10 AM IST
    Chennai: Huawei Telecommunications India, a global leader in ICT solutions and a responsible corporate citizen, made a contribution of lifesaving...
    Apollo Hospitals, Godrej HIT to launch first online Platelet Donor Community

    Apollo Hospitals, Godrej HIT to launch first online Platelet Donor Community

    Ruby Khatun Khatun14 July 2017 9:25 AM IST
    New Delhi: Apollo Hospitals on Tuesday announced its partnership with Godrej Hit to launch India’s first online Platelet Donor Community for dengue...
    Biocon advances over 8 per cent, seeks USFDA approval for breast cancer drug

    Biocon advances over 8 per cent, seeks USFDA approval for breast cancer drug

    Ruby Khatun Khatun13 July 2017 2:19 PM IST
    Mumbai: The stock of Biocon Ltd. surged over 8% in the early morning trade on Wednesday, on the BSE ahead of the USFDA meet to discuss its breast...
    Medtronic Expands TAVR Access to More Patients With Symptomatic, Severe Aortic Stenosis Upon Intermediate Risk FDA Approval

    Medtronic Expands TAVR Access to More Patients With Symptomatic, Severe Aortic Stenosis Upon Intermediate Risk FDA Approval

    Ruby Khatun Khatun12 July 2017 9:46 AM IST
    DUBLIN: Medtronic plc announced the expanded U.S. Food and Drug Administration (FDA) approval of the self-expanding CoreValve(TM) Evolut(TM)...
    Alembic Pharma receives USFDA Tentative Approval for Dabigatran Etexilate Capsules

    Alembic Pharma receives USFDA Tentative Approval for Dabigatran Etexilate Capsules

    Ruby Khatun Khatun11 July 2017 10:09 AM IST
    Vadodara: Alembic Pharmaceuticals Limited announced that the company has received tentative approval from the US Food & Drug Administration...
    Lupin pushes Nifty Pharma index higher by 1 percent

    Lupin pushes Nifty Pharma index higher by 1 percent

    supriya kashyap kashyap9 July 2017 9:16 AM IST
    Mumbai : Pharma major, Lupin Limited during morning’s trade was rallying on the bourses, helping the Nifty Pharma to gain over 1 percent in the...
    FDA Approves VNS Therapy Treatment for Drug-Resistant Epilepsy in young Children

    FDA Approves VNS Therapy Treatment for Drug-Resistant Epilepsy in young Children

    Ruby Khatun Khatun9 July 2017 9:15 AM IST
    LONDON: LivaNova PLC (“LivaNova” , medical technology company, announced it received FDA approval of its VNS Therapy® system (“VNS Therapy”) in...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers

    Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Nestle, 5 Top Hospitals Including Gangaram, Manipal under scanner over clinical trials on 75 premature infants: Govt asks ICMR to probe

    Nestle, 5 Top Hospitals Including Gangaram, Manipal under scanner over clinical trials on 75...

    Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

    Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok